JPM26: Eli Lilly’s obesity drugs target commercial and governmental access

Eli Lilly has further expanded its weight-loss initiatives with novel therapies such as orforglipron, an oral GLP-1 receptor ...
Verywell Health on MSN

Wegovy Now Comes in a Pill. Here’s How It Compares to the Injection

Wegovy is now available as a daily pill, but experts say strict dosing schedules and more intense side effects may not make it a better option than the injection.
Everyday Health on MSN

Here are the best telehealth companies for Ozempic and GLP-1 therapy in 2026

Ozempic may be more expensive and harder to find now that compounded semaglutide isn’t available. Here are seven reputable ...